Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
James Schoeneck Insider Profile
4 Followers
James Schoeneck, President & CEO, Director at Assertio Therapeutics, holds 6.37K shares in Assertio Therapeutics (Ticker: ASRT), holds ― shares in AnaptysBio (Ticker: ANAB), holds 992.09K shares in Calidi Biotherapeutics (Ticker: CLDI).
James Schoeneck Assertio Therapeutics (ASRT)President & CEO, Director
Assertio Therapeutics (ASRT)
President & CEO, Director
Ranked #3,871 out of 100,202 Corporate Insiders
Profitable Transactions
5 out of 7 Profitable Transactions
Average Return
+54.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that James Schoeneck holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Aug 04, 2014 - Aug 04, 2015
Return:+180.00%
The most profitable trade made by James Schoeneck
James Schoeneck's Trading History
Assertio Therapeutics
Dec 27, 2016
President & CEO, Director
Uninformative Buy
―
$5.63K
AnaptysBio
―
Director
―
―
Calidi Biotherapeutics
Jul 02, 2024
Director
Uninformative Buy
―
$1.35M
FibroGen
Jun 09, 2023
Director
Uninformative Buy
―
$41.00K
List of latest transactions for each holding click on a transaction to see James Schoeneck's performance on stock
You May Also Like
James Schoeneck insider profile FAQ
What is the percentage of profitable transactions made by James Schoeneck?
The percentage of profitable transactions made by James Schoeneck is 71%.
What is the average return per transaction made by James Schoeneck?
The average return per transaction made by James Schoeneck is 54.60%.
What stocks does James Schoeneck hold?
James Schoeneck holds: ASRT, ANAB, CLDI, FGEN stocks.
What was James Schoeneck’s latest transaction?
James Schoeneck latest transaction was an Uninformative Buy of ―.
What was James Schoeneck's most profitable transaction?
James Schoeneck’s most profitable transaction was an Informative Buy of ASRT stock on August 4, 2014. The return on the trade was 180.00%.
What is James Schoeneck's role in Assertio Therapeutics?
James Schoeneck's role in Assertio Therapeutics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.